Medlogix Pharma Private Limited, a active private limited company, was established on 21 September 2018 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999TN2018PTC124792. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.20 Cr.
Its leadership includes Munusamysah Srinivasan (Director), Krishnamoorthi Madhanagopal (Director), Gunasekaran Rajakumar (Ceo). Past directors included Kannan Arun Kumar, Shoba Prakash, Chandramohan Vignesh. It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 21 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.35/2A, Chettiyar Agaram Main Road Karambakkam, Chennai, Tamil Nadu, 600077.
U74999TN2018PTC124792
124792
21 September 2018
₹2.00 Cr
₹1.20 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Medlogix Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Munusamysah Srinivasan | Director | 19 Jan 2020 | Current |
| Krishnamoorthi Madhanagopal | Director | 21 Sep 2018 | Current |
| Gunasekaran Rajakumar | Ceo | 12 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Jun 2022 | Past |
| Pramod Abcsdd | Additional Director | 27 Dec 2020 | Past |
| Pramod Abcsdd | Director | 20 Jun 2022 | Past |
| Pramod Abcsdd | Additional Director | 27 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 27 Dec 2020 | Past |
| Pramod Abcsdd | Director | 05 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medlogix Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2019, Medlogix Pharma had a promoter holding of 32.00% and a public holding of 68.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2025 | Others | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medlogix Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medlogix Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medlogix Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 101052069 was registered on 29 Jan 2025. was recorded as a recent event.
Gunasekaran Rajakumar was appointed as a Ceo was appointed as a Ceo on 14 Dec 2024 & has been associated with this company since 11 months 24 days . was recorded as a recent event.
Progress on Gunasekaran Rajakumar was appointed as a CEO was appointed as a CEO on 12 Dec 2024 & has been associated with this company since 11 months 26 days . was documented.
Progress on Medlogix Pharma Private Limited last Annual general meeting of members was held on 21 Sep 2024 as per latest MCA records. was documented.
The activity Medlogix Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
Munusamysah Srinivasan was appointed as a Director was appointed as a Director on 19 Jan 2020 & has been associated with this company since 5 years 10 months . was recorded as a recent event.
The CIN of Medlogix Pharma Private Limited is U74999TN2018PTC124792.
Medlogix Pharma Private Limited is headquartered at No.35/2A, Chettiyar Agaram Main Road Karambakkam, Chennai, Tamil Nadu, 600077.
Medlogix Pharma Private Limited was incorporated on 21 September 2018.
The current directors of Medlogix Pharma Private Limited are
The primary industry of Medlogix Pharma Private Limited is Pharma.
Medlogix Pharma Private Limited is unlisted.
The authorized capital of Medlogix Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.20 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX